𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Boronated Monoclonal Antibody 225.28S for Potential Use in Neutron Capture Therapy of Malignant Melanoma

✍ Scribed by TAMAT, SWASONO R. ;MOORE, DOUGLAS E. ;PATWARDHAN, ADITI ;HERSEY, PETER

Book ID
111259321
Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
321 KB
Volume
2
Category
Article
ISSN
0893-5785

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Synthesis of boronated phenanthridinium
Synthesis of boronated phenanthridinium derivatives for potential use in boron neutron capture therapy (BNCT)
✍ Hadi Ghaneolhosseini; Werner Tjarks; Stefan SjΓΆberg πŸ“‚ Article πŸ“… 1997 πŸ› Elsevier Science 🌐 French βš– 406 KB

3, -p-carborane-l-yl)propyl]-6-phenyl phenanthridinium chloride hydrochloride (13) has been synthesised by reacting 3,8-diacetamido-6-phenylphenanthridine ) in nitrobenzene at 120Β°C for 4 days and subsequent removal of the protective groups using 33% HBr/AcOH. Conversion to the chloride hydrochlori

Boronation of antibodies with mercaptoun
Boronation of antibodies with mercaptoundecahydro-closo-dodecaborate(2-) anion for potential use in boron neutron capture therapy
✍ Fazlul Alam; Albert H. Soloway; Rolf F. Barth πŸ“‚ Article πŸ“… 1987 πŸ› Elsevier Science βš– 455 KB

The anionic polyhedral borane derivative, mercaptoundecahydro-closo-dodecaborate(2-), has been evaluated as a boronating agent for antibodies. The objective of these studies was the selective delivery of boron to neoplasms for neutron capture therapy. Incubation of a large excess of this anion with